Wednesday, April 7, 2010 as of 11:14 AM ET
Geron Corporation is a biotechnology company located in Menlo Park, California that specializes in developing and commercialization of products in three specific areas: 1) therapeutic products for cancer that inhibit telomerase; 2) pharmaceuticals that activate telomerase in tissues impacted by cell aging, injury or degenerative diseases; and 3) cell-based therapies derived from human embryonic stem cells for treatment of various chronic diseases.
Read More at Wikipedia ›Stock futures were pointing to a lower opening as traders await the release of minutes from the Federal Reserve ’s September meeting and ahead of earnings from bellwether Intel Corp after the closing bell.
Here are some early-market movers for Tuesday.ActivIdentity ( NASDAQ : ACTI)The digital identity insurance company announced it would be acquired by Swedish lock maker Assa Abloy for $162 million which sent sent shares soaring 42.5% in pre-market trading.King Pharmaceuticals (NYSE: KG)Shares of the pharmaceutical company jumped 39.1% in pre-market trading after announcing it would be acquired by Pfizer for $14.25 per share in a deal valued at $3.6 billion.Geron Corp. (NASDAQ: GERN)Shares of the biopharmaceutical company were up 4.4% in pre-market trading Tuesday after announcing late Monday that the first human trial of its embryonic stem cell treatment had started.Global Payments Inc (NYSE: GPN)The electronic payment transaction company posted first-quarter results below expectations...Geron (NASDAQ:GERN) ticked 7% higher Monday after announcing the first patient enrollment in its clinical trial of a stem cell-based drug being studied as a treatmen...
There's No Business Like FOX BusinessBoosted by a surprise tumble in weekly jobless claims, Wall Street closed in the green for the sixth time in seven sessions on T...
Stock futures were pointing to a higher opening ahead of manufacturing and construction spending data due out later this morning. Here are some early-market movers f...
